UK markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.14000.0000 (0.00%)
At close: 03:55PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 8.91M
Enterprise value 8.70M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)100.06
Price/book (mrq)5.13
Enterprise value/revenue 124.38
Enterprise value/EBITDA -2.26

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-29.95%
S&P500 52-week change 322.36%
52-week high 33.8000
52-week low 30.8220
50-day moving average 31.8196
200-day moving average 31.8378

Share statistics

Avg vol (3-month) 32.72M
Avg vol (10-day) 31.02M
Shares outstanding 5416.44M
Implied shares outstanding 6420.29M
Float 8243.16M
% held by insiders 143.00%
% held by institutions 124.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,855.94%

Management effectiveness

Return on assets (ttm)-53.90%
Return on equity (ttm)-159.35%

Income statement

Revenue (ttm)69.96k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -2.57M
Net income avi to common (ttm)-2.99M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)210.58k
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.17
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.38M
Levered free cash flow (ttm)-1.48M